SNORC

Chr 2

secondary ossification center associated regulator of chondrocyte maturation

Also known as: ASCL830, C2orf82, UNQ830

The protein regulates chondrocyte maturation and postnatal endochondral ossification, and may inhibit FGF2-induced cell growth stimulation. Mutations in SNORC cause skeletal dysplasia and the inheritance pattern has not been definitively established in the literature. The gene shows moderate constraint against loss-of-function variants, suggesting some intolerance to complete protein loss.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
1
Pubs (1 yr)
32
P/LP submissions
P/LP missense
1.02
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySNORC
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.60) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
32 unique Pathogenic / Likely Pathogenic· 6 VUS of 40 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
1.02LOEUF
pLI 0.602
Z-score 1.58
OE 0.00 (0.001.02)
Moderately constrained

Highly tolerant — LoF variants common in population

Missense Constraint
0.36Z-score
OE missense 0.87 (0.691.10)
50 obs / 57.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.00 (0.001.02)
00.351.4
Missense OE0.87 (0.691.10)
00.61.4
Synonymous OE0.78
01.21.6
LoF obs/exp: 0 / 2.9Missense obs/exp: 50 / 57.7Syn Z: 0.90
DN
0.6260th %ile
GOF
0.73top 25%
LOF
0.2385th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

40 submitted variants in ClinVar

Classification Summary

Pathogenic31
Likely Pathogenic1
VUS6
31
Pathogenic
1
Likely Pathogenic
6
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
31
Likely Pathogenic
1
VUS
6
Likely Benign
0
Benign
0
Total38

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SNORC · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →